Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Klinička primjena piperacilina/tazobaktama (CROSBI ID 100675)

Prilog u časopisu | stručni rad

Škerk, Višnja ; Schonwald, Slavko ; Krhen, Ivan ; Čeljuska, Tošev ; Kopričanec , Maja ; Ledić Drvar, Danijela Klinička primjena piperacilina/tazobaktama // Infektološki glasnik, 22 (2002), 4; 159-161-x

Podaci o odgovornosti

Škerk, Višnja ; Schonwald, Slavko ; Krhen, Ivan ; Čeljuska, Tošev ; Kopričanec , Maja ; Ledić Drvar, Danijela

hrvatski

Klinička primjena piperacilina/tazobaktama

Piperacillin/tazobactam is the most effective combination of penicillin and beta-lactamase inhibitors in the treatment of infections caused by strains that excrete beta-lactamase of wider spectrum. In the hospital setting it is proved to reduce the risk from selecting strains that produce wide spectrum beta-lactamases, so that its administration contributes to decrease in the antimicrobial resistance rates. In the period from 2000 to 2002, 23 hospitalized patients with complicated urinary tract infections were treated with piperacillin/tazobactam at the University Hospital for Infectious Diseases "Dr. Fran Mihaljević", in Zagreb. A total of 20 patients were cured, and three experienced a relapse. Although piperacillin/tazobactam is one of the most expensive antimicrobial drugs, looking long-term, we believe that in certain patients it should be administered more often.

piperacilin/tazobaktam; uroinfekcije

nije evidentirano

engleski

Clinical use of piperacillin/tazobactam

nije evidentirano

piperacillin/tazobactam; uroinfections

nije evidentirano

Podaci o izdanju

22 (4)

2002.

159-161-x

objavljeno

1331-2820

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost